CD86 and Atherosclerotic lesion: According to the previous studies, the data have shown that the CD28/CTLA-4-CD80/CD86 pathway plays an important role in accelerating the development of atherosclerotic lesions, and was considered as an important potential target in immune regulation of atherosclerosis.